E
PharmaCielo Ltd.
PCLOF
$0.0478
-$0.0067-12.29%
E
Sell
4/21/2023Downgrade
PharmaCielo Ltd. (PCLOF) was downgraded to E+ from D- on 4/21/2023 due to a decline in the volatility index, valuation index and total return index.
PharmaCielo Ltd. (PCLOF) was downgraded to E+ from D- on 4/21/2023 due to a decline in the volatility index, valuation index and total return index.
D
Sell
4/6/2023Upgraded
PharmaCielo Ltd. (PCLOF) was upgraded to D- from E+ on 4/6/2023 due to an increase in the total return index and volatility index.
PharmaCielo Ltd. (PCLOF) was upgraded to D- from E+ on 4/6/2023 due to an increase in the total return index and volatility index.
E
Sell
3/14/2023Downgrade
PharmaCielo Ltd. (PCLOF) was downgraded to E+ from D on 03/14/2023.
PharmaCielo Ltd. (PCLOF) was downgraded to E+ from D on 03/14/2023.
D
Sell
2/9/2023Upgraded
PharmaCielo Ltd. (PCLOF) was upgraded to D from E+ on 02/09/2023.
PharmaCielo Ltd. (PCLOF) was upgraded to D from E+ on 02/09/2023.
E
Sell
2/8/2023Downgrade
PharmaCielo Ltd. (PCLOF) was downgraded to E+ from D on 2/8/2023 due to a noticeable decline in the solvency index, total return index and volatility index. The quick ratio declined from 1.36 to 0.09, and debt to equity increased from 0.7 to 1.32.
PharmaCielo Ltd. (PCLOF) was downgraded to E+ from D on 2/8/2023 due to a noticeable decline in the solvency index, total return index and volatility index. The quick ratio declined from 1.36 to 0.09, and debt to equity increased from 0.7 to 1.32.
D
Sell
5/16/2022Upgraded
PharmaCielo Ltd. (PCLOF) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index and total return index.
PharmaCielo Ltd. (PCLOF) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index and total return index.
E
Sell
5/13/2022Downgrade
PharmaCielo Ltd. (PCLOF) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index and total return index.
PharmaCielo Ltd. (PCLOF) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index and total return index.
D
Sell
5/4/2022Upgraded
PharmaCielo Ltd. (PCLOF) was upgraded to D from E+ on 5/4/2022 due to an increase in the valuation index, growth index and solvency index.
PharmaCielo Ltd. (PCLOF) was upgraded to D from E+ on 5/4/2022 due to an increase in the valuation index, growth index and solvency index.
E
Sell
5/1/2022Downgrade
PharmaCielo Ltd. (PCLOF) was downgraded to E+ from D on 5/1/2022 due to a decline in the valuation index and solvency index. Debt to equity increased from 0.13 to 0.38.
PharmaCielo Ltd. (PCLOF) was downgraded to E+ from D on 5/1/2022 due to a decline in the valuation index and solvency index. Debt to equity increased from 0.13 to 0.38.
D
Sell
4/21/2022Upgraded
PharmaCielo Ltd. (PCLOF) was upgraded to D from E+ on 04/21/2022.
PharmaCielo Ltd. (PCLOF) was upgraded to D from E+ on 04/21/2022.
E
Sell
4/20/2022Downgrade
PharmaCielo Ltd. (PCLOF) was downgraded to E+ from D on 4/20/2022 due to a large decline in the total return index and solvency index. The quick ratio declined from 1.35 to 0.72, and debt to equity increased from 0.1 to 0.13.
PharmaCielo Ltd. (PCLOF) was downgraded to E+ from D on 4/20/2022 due to a large decline in the total return index and solvency index. The quick ratio declined from 1.35 to 0.72, and debt to equity increased from 0.1 to 0.13.
D
Sell
11/9/2021Upgraded
PharmaCielo Ltd. (PCLOF) was upgraded to D from E+ on 11/09/2021.
PharmaCielo Ltd. (PCLOF) was upgraded to D from E+ on 11/09/2021.
E
Sell
11/8/2021Downgrade
PharmaCielo Ltd. (PCLOF) was downgraded to E+ from D on 11/8/2021 due to a decline in the volatility index, growth index and solvency index. Total revenue declined 31.93% from $533.4 to $363.1, and earnings per share declined from -$0.0371 to -$0.0402.
PharmaCielo Ltd. (PCLOF) was downgraded to E+ from D on 11/8/2021 due to a decline in the volatility index, growth index and solvency index. Total revenue declined 31.93% from $533.4 to $363.1, and earnings per share declined from -$0.0371 to -$0.0402.
D
Sell
12/29/2020Upgraded
PharmaCielo Ltd. (PCLOF) was upgraded to D from D- on 12/29/2020 due to an increase in the volatility index and total return index.
PharmaCielo Ltd. (PCLOF) was upgraded to D from D- on 12/29/2020 due to an increase in the volatility index and total return index.
D
Sell
12/1/2020Downgrade
PharmaCielo Ltd. (PCLOF) was downgraded to D- from D on 12/1/2020 due to a decline in the valuation index, growth index and solvency index. Total revenue declined 97.81% from $889.9 to $19.5, operating cash flow declined 38.16% from -$3.92M to -$5.42M, and the quick ratio declined from 1.4 to 0.97.
PharmaCielo Ltd. (PCLOF) was downgraded to D- from D on 12/1/2020 due to a decline in the valuation index, growth index and solvency index. Total revenue declined 97.81% from $889.9 to $19.5, operating cash flow declined 38.16% from -$3.92M to -$5.42M, and the quick ratio declined from 1.4 to 0.97.
D
Sell
11/9/2020Upgraded
PharmaCielo Ltd. (PCLOF) was upgraded to D from D- on 11/9/2020 due to an increase in the volatility index and total return index.
PharmaCielo Ltd. (PCLOF) was upgraded to D from D- on 11/9/2020 due to an increase in the volatility index and total return index.
D
Sell
10/21/2020Downgrade
PharmaCielo Ltd. (PCLOF) was downgraded to D- from D on 10/21/2020 due to a decline in the volatility index.
PharmaCielo Ltd. (PCLOF) was downgraded to D- from D on 10/21/2020 due to a decline in the volatility index.
D
Sell
10/5/2020Upgraded
PharmaCielo Ltd. (PCLOF) was upgraded to D from D- on 10/5/2020 due to an increase in the volatility index.
PharmaCielo Ltd. (PCLOF) was upgraded to D from D- on 10/5/2020 due to an increase in the volatility index.
D
Sell
9/18/2020Downgrade
PharmaCielo Ltd. (PCLOF) was downgraded to D- from D on 9/18/2020 due to a large decline in the solvency index, growth index and volatility index. The quick ratio declined from 1.65 to 1.4, earnings per share declined from -$0.0475 to -$0.0532, and operating cash flow declined 8.24% from -$3.62M to -$3.92M.
PharmaCielo Ltd. (PCLOF) was downgraded to D- from D on 9/18/2020 due to a large decline in the solvency index, growth index and volatility index. The quick ratio declined from 1.65 to 1.4, earnings per share declined from -$0.0475 to -$0.0532, and operating cash flow declined 8.24% from -$3.62M to -$3.92M.
D
Sell
6/2/2020Upgraded
PharmaCielo Ltd. (PCLOF) was upgraded to D from D- on 6/2/2020 due to a major increase in the growth index. Earnings per share increased from -$0.0961 to -$0.0521, and EBIT increased 44.77% from -$9.35M to -$5.16M.
PharmaCielo Ltd. (PCLOF) was upgraded to D from D- on 6/2/2020 due to a major increase in the growth index. Earnings per share increased from -$0.0961 to -$0.0521, and EBIT increased 44.77% from -$9.35M to -$5.16M.
D
Sell
4/23/2020Upgraded
PharmaCielo Ltd. (PCLOF) was upgraded to D- from E+ on 4/23/2020 due to an increase in the volatility index.
PharmaCielo Ltd. (PCLOF) was upgraded to D- from E+ on 4/23/2020 due to an increase in the volatility index.
E
Sell
3/18/2020Downgrade
PharmaCielo Ltd. (PCLOF) was downgraded to E+ from D- on 3/18/2020 due to a decline in the volatility index and total return index.
PharmaCielo Ltd. (PCLOF) was downgraded to E+ from D- on 3/18/2020 due to a decline in the volatility index and total return index.
D
Sell
3/3/2020Upgraded
PharmaCielo Ltd. (PCLOF) was upgraded to D- from E+ on 3/3/2020 due to a large increase in the solvency index, valuation index and growth index. Earnings per share increased from -$0.083 to -$0.0299, and EBIT increased 59.03% from -$7.6M to -$3.12M.
PharmaCielo Ltd. (PCLOF) was upgraded to D- from E+ on 3/3/2020 due to a large increase in the solvency index, valuation index and growth index. Earnings per share increased from -$0.083 to -$0.0299, and EBIT increased 59.03% from -$7.6M to -$3.12M.
E
Sell
10/1/2019Upgraded
PharmaCielo Ltd. (PHCEF) was upgraded to E+ from E on 10/1/2019 due to an increase in the valuation index.
PharmaCielo Ltd. (PHCEF) was upgraded to E+ from E on 10/1/2019 due to an increase in the valuation index.
E
Sell
7/1/2019Upgraded
PharmaCielo Ltd. (PHCEF) was upgraded to E from E- on 7/1/2019 due to an increase in the valuation index.
PharmaCielo Ltd. (PHCEF) was upgraded to E from E- on 7/1/2019 due to an increase in the valuation index.
E
Sell
5/31/2019None
PharmaCielo Ltd. (PCLOF) was downgraded to E- from U on 05/31/2019.
PharmaCielo Ltd. (PCLOF) was downgraded to E- from U on 05/31/2019.
OTC PK
03/10/2025 3:09PM Eastern
Quotes delayed
